Bristol Myers Squibb to consolidate R&D units in San Diego in new complex

Bristol Myers Squibb to consolidate R&D units in San Diego in new complex

Bristol Myers Squibb will soon take up residence in a new R&D campus in San Diego, California, leasing a 427,000 square foot complex in the University Town Center near La Jolla.

The deal continues BMS’s 24-year association with Alexandria Real Estate Equities, which leases more that 900,000 square feet of space to the company in New York, Boston, San Francisco and Seattle, in addition to other space in San Diego.

The agreement will allow BMS to consolidate its R&D units in the area under one roof.

“Having a single campus will accelerate collaboration amongst our company’s research teams and will foster a flexible working ecosystem,” Rupert Vessey, BMS’s EVP of research and early development, said in a statement.

Along with its presence in the United States, BMS has R&D outfits in Belgium, England, France, Italy, Spain, Japan and India.

Alexandria leases or has under construction more than 13 million square feet of space in the San Diego area, much of it to life science companies. Alexandria touts the BMS facility as its “first leading edge, highly sustainable amenity-rich mega campus.”

The building, which features a five-story indoor atrium, is designed to “help enable BMS in its recruitment and retention of top talent,” Daniel Ryan, Alexandria’s regional marketing director in San Diego, said in the release.

BMS’s space is part of a 2 million square foot Alexandria Point complex, with more than 100,000 square feet of amenities including an organic eatery and a wellness and fitness center. Plans also call for a dining options including a rooftop dining deck, a gymnasium, conference space and event lawn.

Share:
error: Content is protected !!